文献速递传染病防控与疫情报告免疫规划

美国2020-2025年急性弛缓性脊髓炎监测更新

Acute Flaccid Myelitis Surveillance - United States, January 2020-December 2025.
PubMed 文献 · MMWR Morb Mortal Wkly Rep · 2026-07-09

本文报告美国2020年1月至2025年12月全国急性弛缓性脊髓炎(AFM)监测结果。期间确诊AFM病例数保持低位(每年17-48例),低于2014、2016和2018年的120-238例;尽管2022、2024和2025年哨点监测发现EV-D68呼吸道疾病增加,但未观察到AFM病例同步增加。约75%确诊病例报告脊灰疫苗接种及时,约半数采集并检测了粪便标本;2022年通过AFM监测粪便标本发现一例未接种疫苗者的脊灰病例。

要点

  • 2020-2025年确诊AFM病例每年17-48例,低于2014、2016、2018年的120-238例。
  • EV-D68呼吸道疾病增加未伴随AFM病例同步增加,期间仅一份AFM标本检出EV-D68。
  • 约75%确诊病例脊灰疫苗接种及时,临床应确保采集粪便标本并报告病例。

核心结论

  • 2020-2025年美国确诊AFM病例数保持低位,未随EV-D68呼吸道疾病增加而同步上升。
  • 约75%确诊病例脊灰疫苗接种及时,2022年通过AFM监测粪便标本发现一例未接种疫苗者的脊灰病例。

研究设计与样本

  • 美国CDC全国AFM监测,报告2020年1月至2025年12月确诊AFM病例。
  • 结合实验室检测、流行病学和临床数据,并与2014、2016、2018年比较。

主要发现

  • 2020-2025年确诊AFM病例每年17-48例,而2014、2016、2018年为每年120-238例。
  • 2022、2024和2025年哨点监测发现EV-D68相关呼吸道疾病增加,但全国AFM病例未同步增加。
  • 期间CDC收到的AFM患者标本中仅一份检出EV-D68。
  • 约75%确诊病例报告脊灰疫苗接种及时,约半数采集并检测了粪便标本。
  • 2022年通过AFM监测粪便标本检测发现一例未接种疫苗者的脊灰病例。

临床怎么用

  • 临床医生应确保对急性起病的弛缓性无力或瘫痪患者采集粪便标本。
  • 临床医生应将所有AFM病例报告至当地卫生部门。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Acute flaccid myelitis (AFM) is a rare but serious neurologic condition that causes paralysis and primarily affects children. Clinically and radiologically, AFM is indistinguishable from the acute flaccid paralysis of poliomyelitis caused by poliovirus. Nationwide surveillance for AFM has been conducted in the United States since 2014, when an increase in AFM was first recognized. Laboratory testing and epidemiologic and clinical data collected through surveillance suggest that enteroviruses, particularly enterovirus D68 (EV-D68), are a common cause of AFM. EV-D68 circulation was associated with biennial peaks in AFM cases in the United States in 2014, 2016, and 2018. This report provides an update to nationwide surveillance of confirmed AFM cases during January 2020-December 2025. During this period, the number of confirmed AFM cases reported to CDC remained low (17-48 cases per year) compared with 2014, 2016, and 2018 (120-238 cases per year). Despite ongoing seasonal enterovirus circulation, including increases in EV-D68-associated respiratory illnesses identified from sentinel surveillance sites in 2022, 2024, and 2025, concurrent increases in AFM cases in nationwide surveillance data were not observed; EV-D68 was detected in one AFM patient specimen received by CDC during this period. A majority (approximately 75%) of confirmed cases of AFM occurred in persons who were reported to be up to date with polio vaccination; approximately one half had stool specimens collected and tested. In 2022, a polio case in an unvaccinated person was identified by testing stool specimens collected through AFM surveillance. Clinicians should ensure that stool samples are collected from patients with acute onset of flaccid weakness or paralysis and report all cases to their local health department.

来源:MMWR Morb Mortal Wkly Rep,查看原文。版权归原作者所有。

引用

  1. Lopez AS, English R, Rogers SL, et al. Acute Flaccid Myelitis Surveillance - United States, January 2020-December 2025. MMWR Morb Mortal Wkly Rep. 2026. PMID: 42424163. doi:10.15585/mmwr.mm7526a1

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。